Founded with a mission to revolutionize cardiac diagnostics, HeartMetrics specializes in developing automated, non-invasive diagnostic algorithms to assess coronary blood flow. Their flagship technology, TAFE TM, leverages contrast dispersion fluid dynamics to analyze standard computed tomography angiography (CTA) images, enabling rapid and accurate identification of coronary diseases that impede blood flow to the heart muscle. By focusing on non-invasive methods, HeartMetrics aims to enhance early detection and treatment of cardiovascular conditions.
HeartMetrics has garnered attention from notable figures and investors in the medical and tech industries, contributing to its credibility and growth. The company’s innovative approach has led to significant achievements in the field of cardiac diagnostics, making it a valuable player in the healthcare market. Through its advanced technology, HeartMetrics has made a substantial impact on improving diagnostic accuracy and patient outcomes in cardiology.
